SigRM offers breakthrough in single-cell epitranscriptomics analysis

Researchers have developed a new tool that will help scientists study how genes are expressed in our cells.

Janssen seeks EMA authorisation for urothelial cancer treatment

Janssen’s erdafitinib is being analysed in Phase II and III clinical trials in advanced urothelial carcinoma patients. Credit: Michael Vi/Shutterstock.com. The Janssen Pharmaceutical Companies of

September 11, 2023

Study uncovers new insights into pain pathways linked with temporomandibular joint disorders

A groundbreaking study has uncovered new insights into the pain pathways associated with temporomandibular joint (TMJ) disorders.

March 13, 2025

A nonprofit does deals in Brazil and India to make low-cost CAR-T cell therapies widely available

In the latest bid to widen access to medicines, a nonprofit is sending technology and materials for making expensive CAR-T cell therapies to the Brazilian

May 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.